ARTG 432290FRED X Flow Re-Direction Endoluminal Device - Stent, vascular, intracranial
ARTG ID: 432290 · Life Healthcare Pty Ltd · MicroVention Europe SARL · Class III · Started January 03, 2024
Good Name: Life Healthcare Pty Ltd - FRED X Flow Re-Direction Endoluminal Device - Stent, vascular, intracranial
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 432290
- Start Date
- January 03, 2024
- Effective Date
- January 03, 2024
- Country
- France
- Address
- 30 bis rue du Vieil Abreuvoir, Saint-Germain-en-Laye, 78100
The FRED X System is intended for endovascular embolization of intracranial neurovascular aneurysms. The FRED X System may also be used with embolic coils for the treatment of intracranial neurovascular lesions.
Access comprehensive regulatory information for FRED X Flow Re-Direction Endoluminal Device - Stent, vascular, intracranial in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 432290 and sponsored by Life Healthcare Pty Ltd, manufactured by MicroVention Europe SARL in France. The device registration started on January 03, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.